EXSCALATE: An extreme-scale in-silico virtual screening platform to evaluate 1 trillion compounds in 60 hours on 81 PFLOPS supercomputers

10/22/2021

∙

The social and economic impact of the COVID-19 pandemic demands the reduction of the time required to find a therapeutic cure. In the contest of urgent computing, we re-designed the Exscalate molecular docking platform to benefit from heterogeneous computation nodes and to avoid scaling issues. We deployed the Exscalate platform on two top European supercomputers (CINECA-Marconi100 and ENI-HPC5), with a combined computational power of 81 PFLOPS, to evaluate the interaction between 70 billions of small molecules and 15 binding-sites of 12 viral proteins of Sars-Cov2. The experiment lasted 60 hours and overall it performed a trillion of evaluations.

READ FULL TEXT

EXSCALATE: An extreme-scale in-silico virtual screening platform to evaluate 1 trillion compounds in 60 hours on 81 PFLOPS supercomputers

Using a Novel COVID-19 Calculator to Measure Positive U.S. Socio-Economic Impact of a COVID-19 Pre-Screening Solution (AI/ML)

Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

Distributed Computing in a Pandemic: A Review of Technologies Available for Tackling COVID-19

Tunable and Portable Extreme-Scale Drug Discovery Platform at Exascale: the LIGATE Approach

Cloud-Based Real-Time Molecular Screening Platform with MolFormer

Sharing pandemic vaccination certificates through blockchain: Case study and performance evaluation

Stochastic-based Neural Network hardware acceleration for an efficient ligand-based virtual screening

EXSCALATE: An extreme-scale in-silico virtual screening platform to evaluate 1 trillion compounds in 60 hours on 81 PFLOPS supercomputers

Related Research

Using a Novel COVID-19 Calculator to Measure Positive U.S. Socio-Economic Impact of a COVID-19 Pre-Screening Solution (AI/ML)

Large-scale ligand-based virtual screening for SARS-CoV-2 inhibitors using deep neural networks

Distributed Computing in a Pandemic: A Review of Technologies Available for Tackling COVID-19

Tunable and Portable Extreme-Scale Drug Discovery Platform at Exascale: the LIGATE Approach

Cloud-Based Real-Time Molecular Screening Platform with MolFormer

Sharing pandemic vaccination certificates through blockchain: Case study and performance evaluation

Stochastic-based Neural Network hardware acceleration for an efficient ligand-based virtual screening